Omnicell Cash on Hand 2010-2025 | OMCL
Omnicell cash on hand from 2010 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
| Omnicell Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2024 | $369 |
| 2023 | $468 |
| 2022 | $330 |
| 2021 | $349 |
| 2020 | $486 |
| 2019 | $127 |
| 2018 | $67 |
| 2017 | $32 |
| 2016 | $54 |
| 2015 | $82 |
| 2014 | $126 |
| 2013 | $105 |
| 2012 | $62 |
| 2011 | $200 |
| 2010 | $184 |
| 2009 | $169 |
| Omnicell Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2025-03-31 | $387 |
| 2024-12-31 | $369 |
| 2024-09-30 | $571 |
| 2024-06-30 | $557 |
| 2024-03-31 | $512 |
| 2023-12-31 | $468 |
| 2023-09-30 | $447 |
| 2023-06-30 | $399 |
| 2023-03-31 | $340 |
| 2022-12-31 | $330 |
| 2022-09-30 | $266 |
| 2022-06-30 | $245 |
| 2022-03-31 | $265 |
| 2021-12-31 | $349 |
| 2021-09-30 | $482 |
| 2021-06-30 | $614 |
| 2021-03-31 | $548 |
| 2020-12-31 | $486 |
| 2020-09-30 | $629 |
| 2020-06-30 | $134 |
| 2020-03-31 | $104 |
| 2019-12-31 | $127 |
| 2019-09-30 | $137 |
| 2019-06-30 | $87 |
| 2019-03-31 | $77 |
| 2018-12-31 | $67 |
| 2018-09-30 | $44 |
| 2018-06-30 | $46 |
| 2018-03-31 | $44 |
| 2017-12-31 | $32 |
| 2017-09-30 | $7 |
| 2017-06-30 | $27 |
| 2017-03-31 | $46 |
| 2016-12-31 | $54 |
| 2016-09-30 | $47 |
| 2016-06-30 | $41 |
| 2016-03-31 | $53 |
| 2015-12-31 | $82 |
| 2015-09-30 | $58 |
| 2015-06-30 | $88 |
| 2015-03-31 | $140 |
| 2014-12-31 | $126 |
| 2014-09-30 | $104 |
| 2014-06-30 | $126 |
| 2014-03-31 | $108 |
| 2013-12-31 | $105 |
| 2013-09-30 | $116 |
| 2013-06-30 | $87 |
| 2013-03-31 | $70 |
| 2012-12-31 | $62 |
| 2012-09-30 | $55 |
| 2012-06-30 | $54 |
| 2012-03-31 | $210 |
| 2011-12-31 | $200 |
| 2011-09-30 | $187 |
| 2011-06-30 | $181 |
| 2011-03-31 | $182 |
| 2010-12-31 | $184 |
| 2010-09-30 | $179 |
| 2010-06-30 | $185 |
| 2010-03-31 | $181 |
| 2009-12-31 | $169 |
| 2009-09-30 | $146 |
| 2009-06-30 | $126 |
| 2009-03-31 | $119 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.291B | $1.112B |
| Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.128B | 58.69 |
| Hims & Hers Health (HIMS) | United States | $11.646B | 121.00 |
| Doximity (DOCS) | United States | $11.561B | 53.52 |
| Tempus AI (TEM) | United States | $10.010B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.435B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.842B | 60.03 |
| Hinge Health (HNGE) | United States | $3.739B | 0.00 |
| Privia Health (PRVA) | United States | $2.547B | 174.08 |
| Enovis (ENOV) | United States | $1.826B | 10.18 |
| Phreesia (PHR) | United States | $1.642B | 0.00 |
| Schrodinger (SDGR) | United States | $1.551B | 0.00 |
| 10x Genomics (TXG) | United States | $1.535B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.527B | 0.00 |
| Azenta (AZTA) | United States | $1.475B | 68.57 |
| Evolent Health (EVH) | United States | $1.334B | 113.60 |
| Claritev (CTEV) | United States | $0.763B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.582B | 0.00 |
| Veradigm (MDRX) | United States | $0.547B | 0.00 |
| Standard BioTools (LAB) | United States | $0.475B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.450B | 0.00 |
| Talkspace (TALK) | United States | $0.430B | 128.50 |
| Outset Medical (OM) | United States | $0.333B | 0.00 |
| TruBridge (TBRG) | United States | $0.329B | 731.00 |
| Health Catalyst (HCAT) | United States | $0.269B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.267B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.231B | 0.00 |
| CapsoVision (CV) | United States | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.149B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.139B | 0.00 |
| American Well (AMWL) | United States | $0.126B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.122B | 0.00 |
| Pulmonx (LUNG) | United States | $0.108B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.104B | 0.00 |
| CareCloud (CCLD) | United States | $0.098B | 3.73 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.091B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.081B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.045B | 0.00 |
| HeartBeam (BEAT) | United States | $0.042B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |